The intrarenal generation of angiotensin II is required for experimental hypertension

Jorge F. Giani(Cedars-Sinai Medical Center), Kenneth E. Bernstein(Cedars-Sinai Medical Center), Alicia A. McDonough(University of Southern California), Kandarp H. Shah(Cedars-Sinai Medical Center), Romer A. González-Villalobos(Cedars-Sinai Medical Center), Zakir Khan(Cedars-Sinai Medical Center), Xiao Z. Shen(Cedars-Sinai Medical Center), Ellen A. Bernstein(Emory University)
Current Opinion in Pharmacology
January 20, 2015
10.1016/j.coph.2015.01.002
Cited by 15

Related Papers

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
|Nature|1991|1.3k
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
|Nature|1995|745
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.
|PubMed|1996|440